Sales and Marketing

Showing 15 posts of 11520 posts found.

FDA approves first ever therapy for ultra rare primary haemophagocytic lymphohistiocytosis

November 21, 2018 Research and Development, Sales and Marketing FDA, Novimmune, pharma, sobi

The partnership of Sobi and Novimmune has revealed that their interferon gamma (IFNγ) blocking antibody Gamifant (emapalumab-lzsg) has received approval …

First-ever all-oral drug for sleeping sickness recommended for approval by EMA committee

November 20, 2018 Manufacturing and Production, Sales and Marketing CHMP, EMA, Europe, Sanofi, fexinidazole, pharma, sleeping sickness

Sanofi’s fexinidazole, the first all-oral therapy for the treatment of human African trypanosomiasis (HAT), or sleeping sickness, has secured a …
shutterstock_138095450

Opioid dependency therapy price hiked 600% since 2014, Senate investigators find

November 20, 2018 Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma

Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …

Pfizer to resume price hiking in 2019; 41 drugs set to increase

November 20, 2018 Manufacturing and Production, Sales and Marketing Pfizer, Trump, pharma, price hikes, price hiking, pricing

American pharma firm Pfizer has revealed plans to increase the prices of 41 medicines, the equivalent of 10% of its …
lilly_entrance_web

Eli Lilly’s Emgality cleared for treatment of migraine in Europe

November 20, 2018 Manufacturing and Production, Sales and Marketing EU, Eli Lilly, Emgality, Europe, migraine, pharma

Eli Lilly’s Emgality (galcanezumab) has secured approval from the European Commission for the prophylaxis of migraine in adult patients who …

Novartis’ Promacta cleared by FDA for first-line use in severe aplastic anaemia

November 19, 2018 Sales and Marketing FDA, Novartis, Promacta, Revolade, US, aplastic anaemia, pharma

Novartis has secured expanded approval from the FDA for Promacta (eltrombopag), allowing it to now be used in combination with …
arnaud_breabout

Mundipharma name GSK veteran as new Senior Vice President & CFO

November 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president

The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …
roche_dark_0

Roche withdraws Tecentriq combo application in first-line renal cell carcinoma

November 19, 2018 Sales and Marketing Cancer, Roche, avastin, pharma, renal cell carcinoma, tecentriq

The EMA has revealed that Roche has chosen to withdraw its marketing application for immunotherapy Tecentriq (atezolizumab) in combination with …
4768764591_9e4f7f0eb8_z

EU rules may be stifling Britain’s biotech industry

November 19, 2018 Sales and Marketing EU, biotech, britain, funding, grants, industry

EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …

MSD’s Keytruda to treat melanoma in England on the Cancer Drugs Fund

November 19, 2018 Sales and Marketing England, MSD, NHS, UK, keytruda, melanoma, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) will now be made available to patients in England via the Cancer Drugs Fund, it …
dog-1194083_960_720

FDA trial may help to cut the number of dogs used in clinical trials

November 19, 2018 Sales and Marketing Animal testing, animal activists, clinical trials, dogs, health, tests

A new study may help to significantly reduce the number of dogs that are used in clinical trials, according to …
david_wehner

Alector strengthens board with three appointments including Facebook CFO David Wehner

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Facebook’s Chief Financial Officer (CFO) David Wehner has joined the board of San Francisco-based biotech Alector, a company that hopes …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
ipsen-logo-big

Ipsen’s Cabometyx gains European approval in hepatocellular carcinoma

November 16, 2018 Medical Communications, Sales and Marketing Cabometyx, carcinoma, ipsen, pharma. European Commission

Ipsen’s Cabometyx has received approval from the European Commission for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular …
2tec9don_400x400

Dermavant appoint Todd Zavodnick as CEO

November 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roivant subsidiary Dermavant has appointed experienced pharma exec Todd Zavodnick as the company’s new CEO. The Rutger’s University graduate will …
The Gateway to Local Adoption Series

Latest content